Clinical Edge Journal Scan

Emergency readmission frequent after curative intent CRC surgery


 

Key clinical point: Every 1 in 5 patients who underwent colorectal cancer (CRC) surgery with curative intent required emergency 30-day readmission, with some requiring extended readmission and surgical re-intervention, highlighting the benefits of additional post-discharge follow-ups in patients at a high risk for preventable readmissions.

Major finding: Overall, 20.5% (95% CI 20.1%-20.9%) of patients were readmitted within 30 days of discharge after CRC surgery with curative intent, with 12.2% (95% CI 11.9%-12.5%) and 1.9% (95% CI 1.8-2.1%) requiring post-discharge extended re-admission and surgical readmission, respectively. A very shortlength of stay (odds ratio [OR] 2.36; 95% CI 1.95-2.87) and an American Society of Anesthesiology score ≥IV (OR 2.21; 95% CI, 1.56-3.13) were the strongest predictors of emergency 30-day readmission.

Study details : The findings are from a retrospective study including 40,782 patients who had undergone colorectal tumor resection with curative intent.

Disclosures: This study was financially supported by local institutional sources. The authors declared no conflicts of interest.

Source: Clausen J et al. Incidence and clinical predictors of 30-day emergency readmission after colorectal cancer surgery - A nationwide cohort study. Colorectal Dis. 2022 (Oct 5). Doi: 10.1111/codi.16349

Recommended Reading

Sigmoidoscopy screening cuts CRC mortality, incidence
MDedge Hematology and Oncology
One-third of pancreatic cancer diagnoses missed on scans
MDedge Hematology and Oncology
Low rectal cancer: Laparoscopic-assisted surgery safe in terms of short-term oncological outcomes
MDedge Hematology and Oncology
Benefits of simultaneous resection of liver metastasis restricted to patients with KRAS wild-type tumors
MDedge Hematology and Oncology
Long-term use of antihypertensive drugs and CRC risk: Is there a link?
MDedge Hematology and Oncology
Longer interval between nCRT and surgery increases tumor regression in LARC
MDedge Hematology and Oncology
Capecitabine consolidation chemotherapy after NCRT improves CR in LARC
MDedge Hematology and Oncology
Special CRC prevention efforts may focus on population with higher serum uric acid levels
MDedge Hematology and Oncology
Preoperative vitamin D levels may influence outcomes in patients with localized CRC undergoing resection
MDedge Hematology and Oncology
Liver-dominant mCRC: Prognostic factors for efficacy outcomes after TARE
MDedge Hematology and Oncology